When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.
12-Jun-2013 - Investment in Almac’s Northern Ireland plant will keep production costs competitive with low-cost economies, according to the company.
10-Jun-2013 - UK healthcare services firm ChoiceOne wants EU and US partners to help grow is Asia-focused CRO unit, Choice Pharma.
15-May-2013 - Yusen Logistics has launched a new air freight service to help UK drug major AstraZeneca ship its products to Australia in a new agreement announced today.
15-May-2013 - PRA International says technology and IT innovation will help it compete with rivals that have moved their service centres to cheaper locations in the East to cut costs.
13-May-2013 - Brand-to-generic conversions have been blamed for “somewhat softer than expected” financial results at McKesson, though significant FY2014 direct revenue growth has been predicted.
22-Apr-2013 - DKSH has upgraded its cold chain infrastructure in Southeast Asia as both small and large manufacturers increase their access needs to emerging markets.
17-Apr-2013 - Globalisation, outsourcing and a move towards biopharmaceuticals are leading innovation for pharma distribution companies, according to DHL Global Forwarding.
17-Apr-2013 - DKSH has won a second deal with a Big Pharma firmin Asia in as many months, with US giant Pfizer signing up the firm as its agent in Cambodia.
15-Apr-2013 - An EMA report says increased Russian participation in European submitted clinical trials is part of a trend away from traditional regions, yet fluctuating legislation may affect numbers.
10-Apr-2013 - High drug industry demand for safety monitoring expertise drove Telerx’s acquisition of Sentrx Safety Solutions says deal broker.
26-Mar-2013 - Evonik gets the thumbs up from the MHRA, Recipharm's approved by Japan and Simcere passes the Chinese regulatory test – welcome to Outsourcing-Pharma’s round-up of GMP accreditation.
13-Mar-2013 - Catalent has penned a deal with CRO ShangPharma as part of a two-pronged plan into China and expects more investments to come.
13-Mar-2013 - Marken says the opening of its new pharma depot is part of a whole strategy within China and was driven by demand from an increase in clinical trials.
07-Mar-2013 - The CDSCO has started prescreening applications to register clinical trial ethics committees in a move designed to streamline the approval process.
05-Mar-2013 - US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.
04-Mar-2013 - Following its acquisition of HCR, Synteract has become a multinational CRO with a presence in 16 countries.
21-Feb-2013 - CiToxLAB says strong revenue growth in 2012 was due to a new global status following its acquisition of Lab Research.
12-Feb-2013 - Swedish CRO Trial Form Support has announced plans to make its second late-stage, IT focused acquisition in the space of three months.
07-Feb-2013 - QPS has acquired Florida-based trial site Miami Research Associates (MRA), adding first-in-man capacity to its US services offering.
05-Feb-2013 - Clinical trials made public by Pfizer did not match internal reports or reflect what was done in studies of the seizure drug gabapentin say researchers calling for revision of journal...
16-Jan-2013 - Variation in site recruitment performance is a major risk factor for CROs and their sponsors according to new research.
15-Jan-2013 - PRA wants to build its late-phase offering in China and has committed to provide staff and knowhow to Wuxi Pharmatech joint venture.
15-Jan-2013 - Cambridge Major Labs’ (CML) new private-equity investor plans to expand the CMO’s chemistry and API business and assess cross selling synergies with other firms in its portfolio.
14-Jan-2013 - United Parcel Service (UPS) has abandoned its bid to buy Holland-based logistics firm TNT Express after the European Commission said it would block the deal.
09-Jan-2013 - Exela Pharma Sciences will invest $8.5million in its research and manufacturing plant in North Carolina. The venture, to be spread over the next three years, will provide 38 new jobs...